top of page
Clock Gears

INSIGHTS

EQUITY CAPITAL MARKETS COMMENTARY

Modest December caps off lackluster year for US ECM.

All sectors were active as market rally continues.

Biotech issuance resilient amidst market volatility.

Growing macroeconomic uncertainty thwarts a recovery in ECM issuance in Setpember.

bottom of page